|
⚲
|
| Keyboard |
| Vavricka John
✚
|
|
|---|---|
| CIK # | 0001829630 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001829630] | |
| 4 | [0001829630] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Vavricka John | |
| Atea Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Atea Pharmaceuticals Inc AVIR
Common Stock
|
2026-01-31 | Tax withheld | 11,570 | $4.24 | 49,057 |
|
Atea Pharmaceuticals Inc AVIR
Restricted Stock Units · derivative
|
2026-01-31 | Option exercise | 33,333 | $0.00 | |
|
Atea Pharmaceuticals Inc AVIR
Stock Option (Right to Buy) · derivative
|
2026-01-31 | Grant | 119,520 | $0.00 | |
|
Atea Pharmaceuticals Inc AVIR
Restricted Stock Units · derivative
|
2026-01-31 | Option exercise | 8,750 | $0.00 | |
|
Atea Pharmaceuticals Inc AVIR
Common Stock
|
2026-01-31 | Option exercise | 42,083 | ||
|
Atea Pharmaceuticals Inc AVIR
Common Stock
|
2025-01-31 | Grant | 8,750 | ||
|
Atea Pharmaceuticals Inc AVIR
Common Stock
|
2025-01-31 | Option exercise | 33,333 | ||
|
Atea Pharmaceuticals Inc AVIR
Common Stock
|
2025-01-31 | Tax withheld | 11,517 | $3.06 | 35,242 |
|
Atea Pharmaceuticals Inc AVIR
Restricted Stock Units · derivative
|
2025-01-31 | Option exercise | 33,333 | $0.00 | |
|
Atea Pharmaceuticals Inc AVIR
Stock Option (Right to Buy) · derivative
|
2025-01-31 | Grant | 132,800 | $0.00 | |
|
Atea Pharmaceuticals Inc AVIR
Restricted Stock Units · derivative
|
2025-01-31 | Grant | 8,750 | $0.00 | |
|
Atea Pharmaceuticals Inc AVIR
Common Stock
|
2024-02-01 | Sell | 11,819 | $3.84 | 45,385 |
|
Atea Pharmaceuticals Inc AVIR
Common Stock
|
2024-01-31 | Option exercise | 33,334 | ||
|
Atea Pharmaceuticals Inc AVIR
Restricted Stock Units · derivative
|
2024-01-31 | Option exercise | 33,334 | $0.00 | |
|
Atea Pharmaceuticals Inc AVIR
Stock Option (Right to Buy) · derivative
|
2024-01-31 | Grant | 132,800 | $0.00 | |
|
Atea Pharmaceuticals Inc AVIR
Restricted Stock Units · derivative
|
2023-01-31 | Grant | 100,000 | $0.00 | |
|
Atea Pharmaceuticals Inc AVIR
Stock Option (Right to Buy) · derivative
|
2023-01-31 | Grant | 140,000 | $0.00 | |
|
Atea Pharmaceuticals Inc AVIR
Stock Option (Right to Buy) · derivative
|
2022-01-31 | Grant | 135,000 | $0.00 | |
|
Atea Pharmaceuticals Inc AVIR
Stock Option (Right to Buy) · derivative
|
2021-01-29 | Grant | 117,300 | $0.00 | |
|
Atea Pharmaceuticals Inc AVIR
Series B Convertible Preferred Stock · derivative
|
2020-11-03 | Conversion | 82,508 | ||
| showing 20 of 21 most recent transactions | |||||